The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals BPC 157 Ulcerative Colitis LIVV Natural When will the FDA reclassify BPC 157 to Category 1 Octagon AI